Open AccessImproving colon cancer therapy with a new promising small-molecule activator of the p53-pathway through disruption of p53-MDM2/MDMX interactions
Author(s) -
Liliana Raimundo,
Lucı́lia Saraiva,
Margarida Espadinha,
Joana Soares,
Joana B. Loureiro,
Juliana Calheiros,
Naïr Nazareth,
Joana Almeida,
Marco G. Alves,
Maria M. M. Santos
Publication year - 2019
Publication title -
proceedings of 5th international electronic conference on medicinal chemistry
Language(s) - English
Resource type - Conference proceedings
DOI - 10.3390/ecmc2019-06306
Subject(s) - mdmx , cancer research , mdm2 , clonogenic assay , cancer cell , biology , apoptosis , cell cycle , colorectal cancer , cell cycle checkpoint , cancer , carcinogenesis , chemistry , biochemistry , genetics